Clarius Group, LLC Boston Scientific Corp Transaction History

Clarius Group, LLC

  • $1.4 Billion
  • Q3 2024

A detailed history of Clarius Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Clarius Group, LLC holds 7,958 shares of BSX stock, worth $717,811. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,958
Previous 8,070 1.39%
Holding current value
$717,811
Previous $621,000 7.25%
% of portfolio
0.05%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024
SELL
$72.96 - $84.0 $8,171 - $9,408
-112 Reduced 1.39%
7,958 $666,000
Q2 2024

Jul 11, 2024
SELL
$67.33 - $77.71 $18,246 - $21,059
-271 Reduced 3.25%
8,070 $621,000
Q1 2024

Apr 17, 2024
SELL
$57.6 - $68.62 $68,198 - $81,246
-1,184 Reduced 12.43%
8,341 $571,000
Q4 2023

Jan 29, 2024
SELL
$48.64 - $57.81 $20,574 - $24,453
-423 Reduced 4.25%
9,525 $550,000
Q3 2023

Oct 19, 2023
SELL
$50.19 - $54.68 $107,858 - $117,507
-2,149 Reduced 17.76%
9,948 $525,000
Q2 2023

Aug 09, 2023
BUY
$49.72 - $54.64 $2,983 - $3,278
60 Added 0.5%
12,097 $654,000
Q1 2023

Apr 17, 2023
BUY
$45.09 - $50.03 $2,344 - $2,601
52 Added 0.43%
12,037 $602,000
Q4 2022

Jan 25, 2023
BUY
$39.56 - $47.22 $25,911 - $30,929
655 Added 5.78%
11,985 $555,000
Q3 2022

Oct 24, 2022
SELL
$36.71 - $109.66 $5,176 - $15,462
-141 Reduced 1.23%
11,330 $439,000
Q2 2022

Aug 10, 2022
BUY
$35.24 - $47.1 $43,309 - $57,885
1,229 Added 12.0%
11,471 $428,000
Q4 2021

Feb 02, 2022
BUY
$38.07 - $44.87 $6,433 - $7,583
169 Added 1.68%
10,242 $435,000
Q3 2021

Oct 18, 2021
BUY
$41.23 - $45.88 $31,705 - $35,281
769 Added 8.27%
10,073 $437,000
Q2 2021

Aug 06, 2021
BUY
$38.58 - $44.24 $12,924 - $14,820
335 Added 3.74%
9,304 $398,000
Q1 2021

Apr 27, 2021
BUY
$35.27 - $39.67 $9,170 - $10,314
260 Added 2.99%
8,969 $347,000
Q4 2020

Jan 15, 2021
SELL
$33.15 - $41.97 $22,939 - $29,043
-692 Reduced 7.36%
8,709 $313,000
Q3 2020

Oct 09, 2020
BUY
$34.44 - $42.23 $1,722 - $2,111
50 Added 0.53%
9,401 $359,000
Q2 2020

Jul 08, 2020
BUY
$30.19 - $39.11 $10,747 - $13,923
356 Added 3.96%
9,351 $328,000
Q1 2020

Apr 24, 2020
BUY
$25.83 - $45.71 $24,564 - $43,470
951 Added 11.82%
8,995 $294,000
Q4 2019

Jan 22, 2020
SELL
$37.87 - $45.37 $43,020 - $51,540
-1,136 Reduced 12.37%
8,044 $342,000
Q3 2019

Oct 23, 2019
BUY
$40.31 - $43.45 $95,010 - $102,411
2,357 Added 34.54%
9,180 $374,000
Q2 2019

Aug 02, 2019
SELL
$34.91 - $42.98 $36,515 - $44,957
-1,046 Reduced 13.29%
6,823 $293,000
Q1 2019

May 14, 2019
BUY
$32.91 - $40.75 $258,968 - $320,661
7,869 New
7,869 $302,000

Others Institutions Holding BSX

# of Institutions
1,542
Shares Held
1.19B
Call Options Held
6.79M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email